Pietro Manuel Ferraro Selected Research

Therapeutics

9/2023	Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitors.
7/2023	RAS inhibitors and renal and general mortality in patients with heart failure supported by left ventricular assist devices: a registry study.
1/2011	[Pulmonary-renal syndromes].
1/2009	Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Manuel Ferraro Research Topics

Disease

33	Kidney Calculi (Kidney Stone) 01/2023 - 05/2011
20	Nephrolithiasis 03/2023 - 08/2012
9	Nephrocalcinosis 10/2023 - 11/2016
8	Hypercalciuria 12/2021 - 02/2015
7	Chronic Renal Insufficiency 01/2024 - 06/2010
7	Hypertension (High Blood Pressure) 01/2023 - 05/2013
6	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 01/2009
5	Inflammation (Inflammations) 12/2023 - 05/2012
5	Kidney Diseases (Kidney Disease) 05/2022 - 02/2011
4	Type 2 Diabetes Mellitus (MODY) 12/2023 - 07/2021
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 10/2014
4	Renal Insufficiency (Renal Failure) 10/2023 - 01/2019
4	Heart Failure 07/2023 - 01/2019
4	Autosomal Dominant Polycystic Kidney (ADPKD) 06/2023 - 01/2020
4	Hyperoxaluria (Oxaluria) 01/2023 - 07/2018
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 08/2012
4	Hypercalcemia (Milk Alkali Syndrome) 07/2018 - 01/2017
3	Osteoporosis 05/2024 - 02/2015
3	Urinary Calculi (Urinary Calculus) 12/2023 - 01/2017
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 07/2021
3	Primary Hyperoxaluria (Oxaluria, Primary) 01/2023 - 01/2022
3	Acidosis 09/2022 - 01/2021
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2020
3	Insulin Resistance 07/2021 - 01/2018
3	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2021 - 11/2016
3	Shock 06/2018 - 01/2017
2	Vascular Calcification 03/2024 - 02/2015
2	Renal Colic 12/2023 - 05/2019
2	Cystinuria 12/2023 - 07/2021
2	Urolithiasis 10/2023 - 01/2017
2	Hyperkalemia 09/2023 - 03/2022
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 01/2022
2	Calcium Oxalate Nephrolithiasis 01/2023 - 09/2020
2	Crystalluria 01/2023 - 10/2022
2	Albuminuria 07/2021 - 05/2013
2	Infantile Hypercalcemia 04/2021 - 07/2018
2	Infections 02/2021 - 01/2011
2	Lithiasis 01/2021 - 05/2011
2	Urinary Tract Infections (Urinary Tract Infection) 12/2019 - 01/2017
2	Atherosclerosis 10/2019 - 05/2012
2	Ulcerative Colitis 01/2018 - 01/2012
2	Proteinuria 05/2013 - 01/2009
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2012 - 12/2011
1	Transthyretin-Related Hereditary Amyloidosis 02/2023

Drug/Important Bio-Agent (IBA)

22	CalciumIBA 03/2023 - 05/2011
11	OxalatesIBA 10/2023 - 06/2018
10	AcidsIBA 06/2023 - 10/2016
9	Uric Acid (Urate)IBA 12/2023 - 01/2015
7	SodiumIBA 12/2023 - 05/2011
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2016
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2014
6	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2019
5	Vitamin D3 24-HydroxylaseIBA 03/2023 - 01/2017
5	Calcium OxalateIBA 01/2023 - 01/2018
5	Parathyroid Hormone (Parathormone)IBA 11/2022 - 06/2017
5	Vitamin D FDA LinkGeneric 01/2022 - 01/2017
4	Cystine (L-Cystine)IBA 12/2023 - 02/2021
4	PotassiumIBA 09/2023 - 10/2016
3	dapagliflozinIBA 12/2023 - 07/2021
3	Tolvaptan FDA Link 06/2023 - 01/2020
3	MineralsIBA 06/2023 - 07/2021
3	Insulin (Novolin)FDA Link 07/2021 - 01/2019
3	dirhodium tetraacetate (DRTA)IBA 01/2021 - 11/2016
2	AlkaliesIBA 01/2023 - 01/2021
2	SaltsIBA 01/2023 - 01/2015
2	Phosphates (Orthophosphate)IBA 11/2022 - 07/2021
2	Potassium Citrate FDA LinkGeneric 10/2022 - 09/2019
2	Lipocalin-2IBA 02/2022 - 08/2017
2	Caffeine (No Doz)FDA LinkGeneric 01/2022 - 12/2014
2	lumasiranIBA 01/2022 - 04/2021
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022 - 03/2016
2	ElectrolytesIBA 01/2022 - 01/2021
2	Amino Acids FDA Link 01/2022 - 01/2020
2	CreatinineIBA 07/2021 - 08/2017
2	Furosemide (Lasix)FDA LinkGeneric 01/2021 - 11/2016
2	FludrocortisoneIBA 01/2021 - 11/2016
2	Ammonium Chloride (Sal Ammoniac)FDA Link 01/2021 - 11/2016
2	CytokinesIBA 10/2019 - 12/2011
2	EnzymesIBA 07/2018 - 06/2017
2	CadmiumIBA 05/2011 - 06/2010
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2011 - 01/2009
1	Denosumab FDA Link 05/2024
1	CholesterolIBA 03/2024
1	OsteopontinIBA 03/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2023
1	glycolic acid (glycolate)IBA 10/2023
1	patiromerIBA 09/2023
1	Dietary PotassiumIBA 09/2023
1	sodium zirconium cyclosilicateIBA 09/2023
1	Cystatin CIBA 02/2023
1	ThiazidesIBA 01/2023

Therapy/Procedure

4	Therapeutics 09/2023 - 01/2009
4	Blood Component Removal (Apheresis) 01/2012 - 12/2011
3	Kidney Transplantation 05/2024 - 01/2009
3	Transplantation 01/2023 - 03/2015
3	Percutaneous Coronary Intervention 01/2022 - 07/2021
3	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 06/2018 - 01/2017
2	Renal Dialysis (Hemodialysis) 03/2022 - 01/2019
2	Mediterranean Diet 01/2020 - 10/2014
1	Heart-Assist Devices 07/2023